Seattle Gentics (SGEN) is the Chart of the Day after advancing in 17 sessions and gaining 29.63% in just the last month. Next year analysts predict double digit growth in both Revenue and Earnings.
Article:
The Barchart Chart of the Day is Seattle Genetics (SGEN) and was found by sorting the Barchart New High list for frequency then using the Flipchart function to review the charts. In the last month the stock rose in 17 session for a gain of 29.63% and has a Trend Spotter buy signal. It has great fundamentals for next year.
The Company develops monoclonal antibody-based drugs to treat cancer and related diseases. Using its monoclonal antibody-based technologies and its expertise in cancer, they have assembled a portfolio of drug candidates targeted to many types of human cancers.
Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 96% Barchart technical buy signals'
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 17 new highs and up 29.63% in the last month
- Relative Strength Index 79.95%
- Barchatt computes a technical support level at 33.79
- Recently traded at 34.78 with a 50 day moving average of 29.64
Fundamental factors:
- Market Cap $4.14 billion
- Revenue projected to increase 24.40% next year
- Earnings estimated to grow 33.30% next year
- Analysts issued 3 strong buy, 1 buy, 5 hold and 2 sell reports
- Financial Strength B++
Exit if you lose 10% from your entry point or if the stock trades below its 50 day moving average
No comments:
Post a Comment